Anthony Hayes A Ikido Pharma Inc. (AIKI) insider trading activity

Anthony Hayes is CEO of AIkido Pharma Inc.. Currently has a direct ownership of 686,823 shares of AIKI, which is worth approximately $2.61 Million. The most recent transaction as insider was on Dec 31, 2024, when has been sold 309,118 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 687K

81.84% 3M change

214.33% 12M change

Total Value Held $2.61 Million

Anthony Hayes Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2024	BUY Grant, award, or other acquisition	-	309,118 Added 31.04%	686,823 Common Stock
Jun 11 2024	BUY Grant, award, or other acquisition	-	154,559 Added 29.04%	377,705 Common Stock
May 30 2024	BUY Open market or private purchase	$8,356 $2.4 p/Share	3,482 Added 1.54%	223,146 Common Stock
May 29 2024	BUY Open market or private purchase	$2,605 $2.25 p/Share	1,158 Added 0.52%	219,664 Common Stock
Aug 23 2023	BUY Open market or private purchase	$5,720 $2.86 p/Share	2,000 Added 0.91%	218,506 Common Stock
Aug 16 2023	BUY Open market or private purchase	$5,880 $2.94 p/Share	2,000 Added 0.92%	216,506 Common Stock
Jun 14 2023	BUY Open market or private purchase	$3,785 $2.87 p/Share	1,319 Added 0.61%	214,506 Common Stock
Jun 13 2023	BUY Open market or private purchase	$1,462 $2.89 p/Share	506 Added 0.24%	213,187 Common Stock
May 24 2023	BUY Open market or private purchase	$5,500 $2.75 p/Share	2,000 Added 0.93%	212,681 Common Stock
May 17 2023	BUY Open market or private purchase	$5,540 $2.77 p/Share	2,000 Added 0.94%	210,681 Common Stock
May 16 2023	BUY Open market or private purchase	$5,540 $2.77 p/Share	2,000 Added 0.95%	208,681 Common Stock
Apr 04 2023	BUY Open market or private purchase	$103,200 $3.44 p/Share	30,000 Added 12.68%	206,681 Common Stock
Dec 14 2022	BUY Open market or private purchase	$16,605 $3.69 p/Share	4,500 Added 2.48%	176,681 Common Stock
Dec 13 2022	BUY Open market or private purchase	$18,500 $3.7 p/Share	5,000 Added 2.82%	172,181 Common Stock
Dec 12 2022	BUY Open market or private purchase	$18,100 $3.62 p/Share	5,000 Added 2.9%	167,181 Common Stock
Dec 09 2022	BUY Open market or private purchase	$18,400 $3.68 p/Share	5,000 Added 2.99%	162,181 Common Stock
Dec 08 2022	BUY Open market or private purchase	$17,800 $3.56 p/Share	5,000 Added 3.08%	157,181 Common Stock
Dec 07 2022	BUY Open market or private purchase	$17,400 $3.48 p/Share	5,000 Added 3.18%	152,181 Common Stock
Sep 13 2022	BUY Open market or private purchase	$157,728 $6.32 p/Share	24,957 Added 14.5%	147,181 Common Stock
Sep 12 2022	BUY Open market or private purchase	$241,857 $6.33 p/Share	38,208 Added 23.82%	122,224 Common Stock
Aug 26 2022	BUY Grant, award, or other acquisition	$471,528 $6.0 p/Share	78,588 Added 48.33%	84,016 Common Stock
May 03 2021	BUY Open market or private purchase	$9,900 $0.99 p/Share	10,000 Added 11.31%	78,430 Common Stock
Apr 29 2021	BUY Open market or private purchase	$9,900 $0.99 p/Share	10,000 Added 12.75%	68,430 Common Stock
Apr 22 2021	BUY Open market or private purchase	$9,300 $0.93 p/Share	10,000 Added 14.61%	58,430 Common Stock

Anthony Hayes

CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIKI shares.

Notify only if

Value

Insider Trading

Get notified when an A Ikido Pharma Inc. insider buys or sells AIKI shares.

Notify only if

Operation

Value

Type

News

Receive news related to AIkido Pharma Inc.

Track Activities on AIKI

Account